Yajing Xu

机构：Second Affiliated Hospital of Nanjing Medical University, Changzhou No.2 People's Hospital · ORCID：0000-0001-9228-6648

发表论文 39 篇 · 总被引 381 次 · h-index 8

代表论文

• KLF5/LINC00346/miR‑148a‑3p axis regulates inflammation and endothelial cell injury in atherosclerosis (2021 · International Journal of Molecular Medicine · 被引 34)
• Machine Learning to Predict Contrast-Induced Acute Kidney Injury in Patients With Acute Myocardial Infarction (2020 · Frontiers in Medicine · 被引 33)
• Comparable survival outcomes in HLA-Matched and haploidentical hematopoietic stem cell transplantation for severe aplastic anemia patients aged 40–50: A CBMTR Registry-based propensity score matching analysis over the last decade (2025 · Cancer Letters · 被引 15)
• Identification and Mechanism of the PD-1/PD-L1 Genomic Signature SORL1 as Protective Factor in Bladder Cancer (2021 · Frontiers in Genetics · 被引 8)
• HMPL-306 in relapsed or refractory IDH1- and/or IDH2-mutated acute myeloid leukemia: A phase 1 study (2025 · Med · 被引 7)
• High Expression of RhoBTB3 Predicts Favorable Chemothrapy Outcomes in non-M3 Acute Myeloid Leukemia (2021 · Journal of Cancer · 被引 7)